FMII
DNLI icon

Farmers & Merchants Investments Inc’s Denali Therapeutics DNLI Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-58
Closed -$2K – 1594
2022
Q2 		$2K Hold
58
– – ﹤0.01% 912
2022
Q1 		$2K Hold
58
– – ﹤0.01% 934
2021
Q4 		$3K Hold
58
– – ﹤0.01% 928
2021
Q3 		$3K Buy
+58
New +$3.27K ﹤0.01% 892

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Farmers & Merchants Investments Inc's DNLI Position: Q3 2022 in Review

Farmers & Merchants Investments Inc sold out of Denali Therapeutics (DNLI) in Q3 2022, closing a stake of 58 shares — an estimated $2K sold.

Farmers & Merchants Investments Inc first reported a position in DNLI in Q3 2021 and held it in 4 quarters. The position peaked at $3K in Q4 2021. 200 funds tracked by Wall St. Rank hold DNLI as of Q3 2022.

  • Farmers & Merchants Investments Inc reported no remaining Denali Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 58 Denali Therapeutics shares in Q3 2022, an estimated $2K.
  • Farmers & Merchants Investments Inc first reported a position in Denali Therapeutics in Q3 2021 and held it in 4 quarters.
  • Farmers & Merchants Investments Inc's Denali Therapeutics position peaked at $3K in Q4 2021.
  • 200 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2022.

Based on Farmers & Merchants Investments Inc's 13F filing for Q3 2022, filed 31 Oct 2022.